In the last trading session, 1.34 million shares of the Lipella Pharmaceuticals Inc (NASDAQ:LIPO) were traded, and its beta was 0.44. Most recently the company’s share price was $0.52, and it changed around $0.1 or 23.72% from the last close, which brings the market valuation of the company to $4.16M. LIPO currently trades at a discount to its 52-week high of $2.71, offering almost -421.15% off that amount. The share price’s 52-week low was $0.32, which indicates that the current value has risen by an impressive 38.46% since then. We note from Lipella Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 0.66 million shares, with the 3-month average coming to 3.39 million.
Lipella Pharmaceuticals Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended LIPO as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Lipella Pharmaceuticals Inc is expected to report earnings per share of -0.12 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Lipella Pharmaceuticals Inc (NASDAQ:LIPO) trade information
Instantly LIPO has showed a green trend with a performance of 23.72% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.5700 on recent trading dayincreased the stock’s daily price by 8.77%. The company’s shares are currently down -49.07% year-to-date, but still up 29.88% over the last five days. On the other hand, Lipella Pharmaceuticals Inc (NASDAQ:LIPO) is 31.52% up in the 30-day period. We can see from the shorts that 0.9 million shares have been sold at a short interest cover period of 0.1 day(s).
The consensus price target as assigned by Wall Street analysts is $2, which translates to bulls needing to increase their stock price by 74.0% from its current value. Analyst projections state that LIPO is forecast to be at a low of $2 and a high of $2.
Consensus estimates provided by 0.0 financial analysts predict the company will bring in an average of nan in revenue for the current quarter. 0.0 analysts expect Lipella Pharmaceuticals Inc to make nan in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were nan and nan respectively. Forecasts for the next quarter put sales growth at nan.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -189.86%.
LIPO Dividends
Lipella Pharmaceuticals Inc’s next quarterly earnings report is expected to be released on 2024-Aug-13.
Lipella Pharmaceuticals Inc (NASDAQ:LIPO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 35.49% of Lipella Pharmaceuticals Inc shares, and 7.87% of them are in the hands of institutional investors. The stock currently has a share float of 12.21%.
Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Mar 31, 2024 . The former held 34.52 shares worth $17933.0, making up 0.43% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 25.32 shares worth around $13151.0, which represents about 0.32% of the total shares outstanding.
